Sobhani Maryam, Taheri Ahmad-Reza, Jafarian Amir-Hossein, Hashemy Seyed Isaac
Department of Emergency Medicine, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Dermatology, Imam Reza Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
J Cancer Res Clin Oncol. 2016 Nov;142(11):2303-7. doi: 10.1007/s00432-016-2242-0. Epub 2016 Sep 6.
Basal cell carcinoma (BCC) is the most prevalent cancer worldwide. Different mechanisms are proposed to be involved in its pathogenesis such as oxidative stress. Oxidative stress, which is the consequence of the disruption of redox balance in favor of oxidants, is involved in the initiation or progression of many tumors. Thioredoxin reductase (TrxR) is a key enzyme of the thioredoxin (Trx) system, containing Trx and TrxR and NADPH, which is one of the main cellular oxidoreductases with an essential role in cellular health and survival through providing and maintaining redox balance. Therefore, we aimed to study and compare the activity and tissue distribution of TrxR in tumoral tissue and its healthy margin in patients with BCC.
After biopsy and taking samples from 18 patients, TrxR activity was measured using a commercial kit and its tissue distribution was assessed immunohistochemically.
Both the activity and tissue distribution of TrxR in tumoral tissues were significantly higher compared to their healthy margins. Regarding the tissue distribution, this significant increase in TrxR in tumoral tissues was documented based on both staining intensity and abundance of positive cells in immunohistochemistry.
Based on these results, it is concluded that TrxR is involved in the pathogenesis of BCC; however, more investigations are required to clarify whether this increase is a consequence of BCC or it is an initiating mechanism.
基底细胞癌(BCC)是全球最常见的癌症。其发病机制涉及多种不同的机制,如氧化应激。氧化应激是氧化还原平衡向氧化剂方向破坏的结果,参与许多肿瘤的发生或发展。硫氧还蛋白还原酶(TrxR)是硫氧还蛋白(Trx)系统的关键酶,该系统包含Trx、TrxR和NADPH,是主要的细胞氧化还原酶之一,通过提供和维持氧化还原平衡在细胞健康和存活中发挥重要作用。因此,我们旨在研究和比较BCC患者肿瘤组织及其健康边缘组织中TrxR的活性和组织分布。
对18例患者进行活检并取样后,使用商业试剂盒测量TrxR活性,并通过免疫组织化学评估其组织分布。
与健康边缘组织相比,肿瘤组织中TrxR的活性和组织分布均显著更高。关于组织分布,基于免疫组织化学中染色强度和阳性细胞丰度,肿瘤组织中TrxR的这种显著增加得到了证实。
基于这些结果,得出结论:TrxR参与BCC的发病机制;然而,需要更多的研究来阐明这种增加是BCC的结果还是起始机制。